DK171139B1 - Fremgangsmåde til fremstilling af en polymergenstand med reduceret thrombogenicitet - Google Patents
Fremgangsmåde til fremstilling af en polymergenstand med reduceret thrombogenicitet Download PDFInfo
- Publication number
- DK171139B1 DK171139B1 DK069484A DK69484A DK171139B1 DK 171139 B1 DK171139 B1 DK 171139B1 DK 069484 A DK069484 A DK 069484A DK 69484 A DK69484 A DK 69484A DK 171139 B1 DK171139 B1 DK 171139B1
- Authority
- DK
- Denmark
- Prior art keywords
- approx
- substrate
- process according
- plasma
- surfactant
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 48
- 230000008569 process Effects 0.000 title claims description 23
- 229920000642 polymer Polymers 0.000 title description 10
- 239000000758 substrate Substances 0.000 claims description 47
- 229920000669 heparin Polymers 0.000 claims description 44
- -1 polyethylene Polymers 0.000 claims description 30
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 17
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 17
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
- 239000001301 oxygen Substances 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 239000004094 surface-active agent Substances 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- 238000007654 immersion Methods 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 239000007789 gas Substances 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims description 7
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 6
- 150000002500 ions Chemical class 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000003093 cationic surfactant Substances 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- SVBAPZTYWZGPKN-UHFFFAOYSA-N n-methyldodecan-1-amine;hydrochloride Chemical group Cl.CCCCCCCCCCCCNC SVBAPZTYWZGPKN-UHFFFAOYSA-N 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 229910052786 argon Inorganic materials 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 229920002301 cellulose acetate Polymers 0.000 claims description 2
- 239000001307 helium Substances 0.000 claims description 2
- 229910052734 helium Inorganic materials 0.000 claims description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 2
- 229910052743 krypton Inorganic materials 0.000 claims description 2
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 229910052754 neon Inorganic materials 0.000 claims description 2
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229910052724 xenon Inorganic materials 0.000 claims description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 2
- 229910052753 mercury Inorganic materials 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- GTAFDLSUAZTLQS-UHFFFAOYSA-N n-hexyldodecan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCC[NH2+]CCCCCC GTAFDLSUAZTLQS-UHFFFAOYSA-N 0.000 claims 1
- XTEYYMUHIGUNIC-UHFFFAOYSA-N n-methylhexadecan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[NH2+]C XTEYYMUHIGUNIC-UHFFFAOYSA-N 0.000 claims 1
- NNKSAZWMTWKXLD-UHFFFAOYSA-N n-methyloctadecan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH2+]C NNKSAZWMTWKXLD-UHFFFAOYSA-N 0.000 claims 1
- IBSSBDSZRZSTHK-UHFFFAOYSA-N n-methyltetradecan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCC[NH2+]C IBSSBDSZRZSTHK-UHFFFAOYSA-N 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 39
- 229960002897 heparin Drugs 0.000 description 38
- 239000000463 material Substances 0.000 description 17
- 239000002952 polymeric resin Substances 0.000 description 16
- 229920003002 synthetic resin Polymers 0.000 description 16
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 15
- 229920003023 plastic Polymers 0.000 description 12
- 239000004033 plastic Substances 0.000 description 12
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 238000009832 plasma treatment Methods 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 5
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910015900 BF3 Inorganic materials 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000001453 nonthrombogenic effect Effects 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000002885 thrombogenetic effect Effects 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940032912 zephiran Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
- C08J7/123—Treatment by wave energy or particle radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
- A61L33/0017—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using a surface active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0094—Physical treatment, e.g. plasma treatment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48891183A | 1983-04-27 | 1983-04-27 | |
| US48891183 | 1983-04-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK69484D0 DK69484D0 (da) | 1984-02-15 |
| DK69484A DK69484A (da) | 1984-10-28 |
| DK171139B1 true DK171139B1 (da) | 1996-07-01 |
Family
ID=23941629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK069484A DK171139B1 (da) | 1983-04-27 | 1984-02-15 | Fremgangsmåde til fremstilling af en polymergenstand med reduceret thrombogenicitet |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0124200B1 (https=) |
| JP (1) | JPS59200656A (https=) |
| AU (1) | AU557989B2 (https=) |
| CA (1) | CA1215676A (https=) |
| DE (1) | DE3482446D1 (https=) |
| DK (1) | DK171139B1 (https=) |
| ES (2) | ES8601688A1 (https=) |
| NZ (1) | NZ206247A (https=) |
| ZA (1) | ZA838545B (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61230058A (ja) * | 1985-04-04 | 1986-10-14 | Susumu Kogyo Kk | アルブミンの定量法 |
| JP2504087B2 (ja) * | 1987-12-16 | 1996-06-05 | エヌオーケー株式会社 | 生理活性物質固定化用担体の製造法 |
| US5338770A (en) * | 1988-06-08 | 1994-08-16 | Cardiopulmonics, Inc. | Gas permeable thrombo-resistant coatings and methods of manufacture |
| NZ229354A (en) * | 1988-07-01 | 1990-09-26 | Becton Dickinson Co | Treating polymer surfaces with a gas plasma and then applying a layer of endothelial cells to the surface |
| US4865870A (en) * | 1988-07-07 | 1989-09-12 | Becton, Dickinson And Company | Method for rendering a substrate surface antithrombogenic |
| US4967763A (en) * | 1989-03-13 | 1990-11-06 | Becton, Dickinson And Company | Platelet stable blood collection assembly |
| US5244654A (en) * | 1990-11-08 | 1993-09-14 | Cordis Corporation | Radiofrequency plasma biocompatibility treatment of inside surfaces of medical tubing and the like |
| DE69125828T2 (de) * | 1991-05-21 | 1997-07-31 | Hewlett Packard Gmbh | Verfahren zur Vorbehandlung der Oberfläche eines medizinischen Artikels |
| EP0588895B1 (en) * | 1991-05-31 | 1995-01-11 | Baxter International Inc. | Thromboresistant coating for defoaming applications |
| UA35578C2 (uk) * | 1991-08-16 | 2001-04-16 | Майлс Е. Гелін | Передньокамерний очний імплантат, спосіб його одержання та спосіб лікування короткозорості |
| WO1993005825A1 (en) * | 1991-09-20 | 1993-04-01 | Baxter International Inc. | Processes for reducing the thrombogenicity of biomaterials |
| JP3363282B2 (ja) * | 1995-03-20 | 2003-01-08 | 株式会社クリニカル・サプライ | 潤滑化された表面を有する医療用具及びその製造方法 |
| CA2197375C (en) * | 1996-02-15 | 2003-05-06 | Yasuhiro Okuda | Artificial blood vessel |
| JP2000510720A (ja) * | 1996-05-03 | 2000-08-22 | ユーロス コーポレイション | 医療装置用のペントサンポリスルフェート被膜 |
| AU6140299A (en) | 1998-09-10 | 2000-04-03 | Percardia, Inc. | Tmr shunt |
| US6632470B2 (en) * | 2001-01-31 | 2003-10-14 | Percardia | Methods for surface modification |
| GB0225197D0 (en) * | 2002-10-30 | 2002-12-11 | Univ Sheffield | Surface |
| US8288118B2 (en) | 2007-09-19 | 2012-10-16 | Becton, Dickinson And Company | Method of analyzing various surface chemistries for culturing a given cell line |
| JP5723767B2 (ja) * | 2008-05-27 | 2015-05-27 | エーオー テクノロジー アーゲー | ポリマーの表面改質 |
| JP5956074B2 (ja) | 2012-08-29 | 2016-07-20 | カーディアック ペースメイカーズ， インコーポレイテッド | 医療用リードのための向上した低摩擦コーティングおよび製造方法 |
| EP2922594B1 (en) | 2012-11-21 | 2018-02-14 | Cardiac Pacemakers, Inc. | Medical electrodes with layered coatings |
| GB201416593D0 (en) * | 2014-09-19 | 2014-11-05 | Jozef Stefan Inst And University Of Maribor | Method for immobilization of heparin on a polymeric material |
| CN114106493B (zh) * | 2022-01-24 | 2022-04-29 | 山东大学 | 一种肝素化pvc材料、其制备方法及作为医疗器械的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE757386A (fr) * | 1969-10-13 | 1971-04-13 | Du Pont | Procede de transfert double pour images photodurcissables |
| DE2148011C3 (de) * | 1970-10-05 | 1978-11-09 | Aminkemi Ab | Verfahren zum Herstellen nichtthrombogener Kunststoffoberflächen |
| GB1357011A (en) * | 1970-10-05 | 1974-06-19 | Aminkemi Ab | Method of stabilizing heparinized non-thrombogenic plastic surfaces |
| US4326532A (en) * | 1980-10-06 | 1982-04-27 | Minnesota Mining And Manufacturing Company | Antithrombogenic articles |
-
1983
- 1983-11-07 CA CA000440532A patent/CA1215676A/en not_active Expired
- 1983-11-14 NZ NZ206247A patent/NZ206247A/en unknown
- 1983-11-15 AU AU21371/83A patent/AU557989B2/en not_active Ceased
- 1983-11-16 ZA ZA838545A patent/ZA838545B/xx unknown
- 1983-12-14 ES ES528034A patent/ES8601688A1/es not_active Expired
-
1984
- 1984-01-09 JP JP59001798A patent/JPS59200656A/ja active Granted
- 1984-02-08 EP EP84300805A patent/EP0124200B1/en not_active Expired - Lifetime
- 1984-02-08 DE DE8484300805T patent/DE3482446D1/de not_active Expired - Fee Related
- 1984-02-15 DK DK069484A patent/DK171139B1/da not_active IP Right Cessation
-
1985
- 1985-06-17 ES ES544285A patent/ES8702150A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0124200B1 (en) | 1990-06-13 |
| EP0124200A3 (en) | 1987-01-07 |
| NZ206247A (en) | 1987-05-29 |
| AU557989B2 (en) | 1987-01-15 |
| DK69484A (da) | 1984-10-28 |
| EP0124200A2 (en) | 1984-11-07 |
| ES8702150A1 (es) | 1986-12-16 |
| ZA838545B (en) | 1984-07-25 |
| ES544285A0 (es) | 1986-12-16 |
| AU2137183A (en) | 1984-11-01 |
| ES528034A0 (es) | 1985-11-16 |
| DK69484D0 (da) | 1984-02-15 |
| CA1215676A (en) | 1986-12-23 |
| JPS6128348B2 (https=) | 1986-06-30 |
| JPS59200656A (ja) | 1984-11-14 |
| DE3482446D1 (de) | 1990-07-19 |
| ES8601688A1 (es) | 1985-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK171139B1 (da) | Fremgangsmåde til fremstilling af en polymergenstand med reduceret thrombogenicitet | |
| US4613517A (en) | Heparinization of plasma treated surfaces | |
| US3616935A (en) | Preparation of antithrombogenic surfaces | |
| US4116898A (en) | Non-thrombogenic articles | |
| JP2677360B2 (ja) | 親水特性を有する透過性の多孔質膜およびその製造方法 | |
| US5034265A (en) | Plasma gas discharge treatment for improving the compatibility of biomaterials | |
| US8029562B2 (en) | Wettable ePTFE medical devices | |
| Al-Jumaili et al. | Plasma treatment of polymeric membranes | |
| US5817272A (en) | Process for making a biocompatible porous holllow fiber | |
| WO1989009246A1 (en) | Low coefficient of friction surface | |
| JPH0520109B2 (https=) | ||
| JPH0286822A (ja) | 親水性多孔質膜及びその製造方法並びに該多孔質膜を用いた液体濾過器 | |
| JPS6246190B2 (https=) | ||
| EP1711245A4 (en) | METHOD FOR THE FILLING OF HYDROPHOBIC POROUS POLYMERMERMBRANES FOR IMPROVING THE WATER FLOW WITHOUT ALCOHOL TREATMENT | |
| JPH0236267B2 (https=) | ||
| CN109880140B (zh) | 一种碱缩细菌纳米纤维素管及其制备方法和应用 | |
| CN110772662A (zh) | 一种抗菌膨体聚四氟乙烯面部植入材料及其制备工艺 | |
| CN118873757A (zh) | 一种涂层血流导向支架和制备方法 | |
| JPS6158196B2 (https=) | ||
| EP2997984B1 (en) | Method for immobilization of heparin on a polymeric material | |
| JPS6257613A (ja) | 親水性有機重合体基質の製法 | |
| JP2001323091A (ja) | ポリマーの表面処理方法 | |
| JP3700006B2 (ja) | 工業用フィルター | |
| JP2004035582A (ja) | 表面改質高分子微多孔膜の製造方法 | |
| CA1063889A (en) | Substrates coated with platinum black |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |